<DOC>
	<DOCNO>NCT01251276</DOCNO>
	<brief_summary>Primary objective : = &gt; To describe Seroprotection rate ( SPR ) least 2 year follow completion primary series Hepatitis B vaccine 1 month follow challenge dose HBVaxPro . Secondary Objective : = &gt; To describe safety tolerability challenge dose HBVaxPro adult â‰¥50 year age .</brief_summary>
	<brief_title>Hepatitis B Challenge Dose Adults</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>In general good health base medical history . Received 3 dos Hepatitis B vaccine least 2 year prior enrollment study . Known history previous Hepatitis B infection . History vaccination Hepatitis B vaccine within last 2 year . History febrile illness . Known suspected hypersensitivity component HBVaxPro . Receipt medication / vaccine may interfere study assessment . Known suspect immune impairment . Pregnant woman nurse mother .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>